Posts Tagged ‘2020

September 21, 2020
Our Take: MSSP generated net savings of $1.2 billion for Medicare in 2019
Read More
September 14, 2020
Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine
Read More
August 31, 2020
Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash
Read More
August 24, 2020
Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million
Read More
August 17, 2020
Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers
Read More
August 10, 2020
Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas
Read More
August 03, 2020
Our Take: Late-stage trials of COVID-19 vaccine candidates get underway as BARDA agrees to additional funding for vaccine development, production
Read More
July 27, 2020
Our Take: Trump renews efforts to lower drug prices ahead of election
Read More
July 20, 2020
Our Take: Hospitals to send COVID-19 data directly to HHS, sidelining CDC
Read More
July 13, 2020
Our Take: Walmart discreetly steps into the health insurance business
Read More
June 29, 2020
Our Take: One court says hospitals must disclose prices; another court says drug companies don’t have to
Read More
June 22, 2020
Our Take: Proposed CMS rule facilitates outcomes-based contracts between drug companies, payers
Read More
June 15, 2020
Our Take: AstraZeneca ramps up COVID-19 vaccine manufacturing, distribution capacity with two more deals
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘2020

Our Take: MSSP generated net savings of $1.2 billion for Medicare in 2019

Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine

Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash

Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million

Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers

Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas

Our Take: Late-stage trials of COVID-19 vaccine candidates get underway as BARDA agrees to additional funding for vaccine development, production

Our Take: Trump renews efforts to lower drug prices ahead of election

Our Take: Hospitals to send COVID-19 data directly to HHS, sidelining CDC

Our Take: Walmart discreetly steps into the health insurance business

Our Take: One court says hospitals must disclose prices; another court says drug companies don’t have to

Our Take: Proposed CMS rule facilitates outcomes-based contracts between drug companies, payers

Our Take: AstraZeneca ramps up COVID-19 vaccine manufacturing, distribution capacity with two more deals

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘2020

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives